| USD ($) $ in Millions | LTM | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||
Net income including non-controlling interests | $ 9,667 | $ 10,093 | $ 9,845 | $ 2,156 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 774 | 747 | 737 | 823 | ||||
Bad debt expense | - | - | 61 | 92 | ||||
Stock-based compensation | 1,939 | 1,826 | 1,796 | 1,935 | ||||
Gain on extinguishment of convertible notes and settlement of derivatives | - | - | - | - | ||||
Loss from sale of investments | - | - | 0 | 74 | ||||
Gain on business divestitures | - | - | 0 | (204) | ||||
Deferred income taxes | (3,683) | (4,779) | (6,027) | 26 | ||||
Accretion of discounts on marketable debt securities, net | (158) | (158) | (251) | - | ||||
Impairment of debt and equity securities | - | - | - | - | ||||
Revaluation of derivative liabilities | - | - | - | - | ||||
Accretion of discount on long-term debt | - | - | - | - | ||||
Payment-in-kind interest | - | - | - | - | ||||
Impairments of goodwill, long-lived assets and other assets | - | - | 0 | 86 | ||||
Impairment of equity method investment | - | - | 0 | 0 | ||||
Loss on disposal of property and equipment | - | - | - | - | ||||
Impairment of long-lived assets held for sale | - | - | - | - | ||||
Loss (income) from equity method investments, net | - | - | 38 | (48) | ||||
Unrealized (gain) loss on debt and equity securities, net | - | 97 | (1,832) | (1,610) | ||||
Revaluation of MLU B.V. call option | - | - | 0 | 0 | ||||
Unrealized (gain) loss on debt and equity securities, net | - | - | - | - | ||||
Non-cash deferred revenue | - | - | - | - | ||||
Gain on forfeiture of unvested warrants and related share repurchases | - | - | - | - | ||||
Unrealized foreign currency transactions | - | (120) | 308 | 138 | ||||
Other | 403 | 166 | 88 | (48) | ||||
Change in assets and liabilities, net of impact of business acquisitions and disposals: | ||||||||
Accounts receivable | (630) | (466) | (142) | (758) | ||||
Prepaid expenses and other assets | (655) | (1,028) | (694) | (1,462) | ||||
Collateral held by insurer | - | - | - | 0 | ||||
Operating lease right-of-use assets | 188 | 177 | 196 | 191 | ||||
Accounts payable | 340 | 126 | 86 | 64 | ||||
Accrued insurance reserves | 2,003 | 2,660 | 2,819 | 2,015 | ||||
Accrued expenses and other liabilities | 463 | 967 | 330 | 295 | ||||
Operating lease liabilities | (199) | (209) | (221) | (180) | ||||
Net cash provided by operating activities | 10,424 | 10,099 | 7,137 | 3,585 | ||||
Cash flows from investing activities | ||||||||
Proceeds from sale and disposal of property and equipment | - | - | - | - | ||||
Proceeds from insurance reimbursement, sale and disposal of property and equipment | - | - | - | - | ||||
Purchases of property and equipment | (308) | (336) | (242) | (223) | ||||
Purchases of non-marketable equity securities | (992) | (676) | (289) | (52) | ||||
Purchase of intangible assets | - | - | - | - | ||||
Purchases of equity method investments | - | - | - | - | ||||
Purchase of non-marketable debt securities | - | - | - | - | ||||
Purchases of marketable securities | (31,458) | (21,447) | (12,765) | (8,774) | ||||
Proceeds from sale of non-marketable equity securities | - | - | - | 0 | ||||
Proceeds from maturities and sales of marketable securities | 27,678 | 20,046 | 10,204 | 5,069 | ||||
Proceeds from sale of equity method investments | 0 | 0 | 17 | 721 | ||||
Proceeds from business divestiture | - | - | 0 | 0 | ||||
Acquisition of businesses, net of cash acquired | (664) | (815) | 0 | 0 | ||||
Return of capital from equity method investee | - | - | - | - | ||||
Purchase of notes receivables | - | - | - | 0 | ||||
Other investing activities | (41) | (336) | (102) | 33 | ||||
Net cash used in investing activities | (7,723) | (3,564) | (3,177) | (3,226) | ||||
Cash flows from financing activities | ||||||||
Proceeds from exercise of stock options, net of repurchases | - | - | - | - | ||||
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan | 199 | 183 | 156 | 130 | ||||
Repurchase of outstanding shares | - | - | - | - | ||||
Issuance of term loan and notes, net of issuance costs | - | 3,359 | 3,972 | 2,824 | ||||
Purchase of Capped Calls | - | - | 0 | (141) | ||||
Principal repayment on term loan and notes | (4,350) | (2,350) | (3,986) | (2,675) | ||||
Principal repayment on Careem Notes | - | - | 0 | (25) | ||||
Proceeds from revolving lines of credit | - | - | - | - | ||||
Principal repayment on revolving lines of credit | - | - | - | - | ||||
Principal payments on finance leases | (164) | (157) | (172) | (171) | ||||
Proceeds from issuance of common stock upon initial public offering, net of offering costs | - | - | - | - | ||||
Taxes paid related to net share settlement of equity awards | - | - | - | - | ||||
Proceeds from issuance of common stock related to private placement | - | - | - | - | ||||
Proceeds from issuance and sale of subsidiary stock units | - | - | 0 | 0 | ||||
Repurchases of common stock | (6,904) | (6,523) | (1,252) | - | ||||
Redemption of non-controlling interests | (109) | (109) | (851) | - | ||||
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | - | - | - | - | ||||
Dissolution of joint venture and subsequent proceeds | - | - | - | - | ||||
Repurchase of stock subject to put options related to Yandex | - | - | - | - | ||||
Other financing activities | (108) | (116) | 46 | (37) | ||||
Net cash used in financing activities | (5,207) | (5,713) | (2,087) | (95) | ||||
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | 16 | 215 | (267) | 63 | ||||
Net increase in cash and cash equivalents, and restricted cash and cash equivalents | (2,490) | 1,037 | 1,606 | 327 | ||||
Cash and cash equivalents, and restricted cash and cash equivalents | ||||||||
Reclassification from (to) assets held for sale during the period | - | - | - | 0 | ||||
Supplemental disclosures of cash flow information | ||||||||
Cash paid for: | ||||||||
Interest, net of amount capitalized | 399 | 386 | 475 | 629 | ||||
Income taxes, net of refunds | 458 | 345 | 324 | 234 | ||||
Non-cash investing and financing activities: | ||||||||
Finance lease obligations | - | - | 4 | 216 | ||||
Stock-based compensation capitalized as software development costs | - | - | - | - | ||||
Changes in purchases of property, equipment and software recorded in accounts payable and accrued liabilities | - | - | - | - | ||||
Changes in share repurchase commitment made in each period | - | - | - | - | ||||
Financed construction projects | - | - | - | - | ||||
Right-of-use assets obtained in exchange for lease obligations | - | - | 132 | 84 | ||||
Deferred unpaid offering costs | - | - | - | - | ||||
Settlement of litigation through issuance of redeemable convertible preferred stock | - | - | - | - | ||||
Common stock issued in connection with acquisitions | - | - | - | 0 | ||||
Ownership interest in MLU B.V. received in connection with the disposition of Uber Russia/CIS operations | - | - | - | - | ||||
Grab debt security received in exchange for the sale of Southeast Asia operations | - | - | - | - | ||||
Ownership interest received in exchange for divestitures | 0 | 0 | 0 | 300 | ||||
Issuance of Careem Notes including the holdback amount | - | - | - | - | ||||
Holdback amount of unsecured convertible notes in connection with Careem acquisition | - | - | - | - | ||||
Conversion of redeemable convertible preferred stock to common stock upon initial public offering | - | - | - | - | ||||
Conversion of convertible notes to common stock upon initial public offering | - | - | - | - | ||||
Conversion of convertible notes to common stock related to Careem | - | - | - | $ 0 |